Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Dow in Worst Week Since October; GME Jumps Despite Robinhood Limits

Published 2021-01-29, 04:29 p/m
Updated 2021-01-29, 04:35 p/m
© Reuters

By Yasin Ebrahim

Investing.com -  The Dow closed lower Friday, suffering its worst weekly decline since October after a jolt of volatility swept through markets as the short-squeeze trade resumed even as trading platforms hampered retail traders.  

The Dow Jones Industrial Average fell 2.03%, or 620 points, but was down more than 700 points intraday. The S&P 500 was down 1.93%, while the Nasdaq Composite fell 2%.

Easing trading restrictions on several platforms prompting retailer traders to put the squeeze on short-sellers once again. GameStop Corp (NYSE:GME) jumped 70% to lead the pack of  short-squeeze stocks including AMC Entertainment Holdings Inc (NYSE:AMC), Express Inc (NYSE:EXPR), BlackBerry (NYSE:BB), Nokia Corp ADR (NYSE:NOK) and Bed Bath & Beyond (NASDAQ:BBBY).

 
The short-squeeze stocks eased from their highs, but held the bulk of their gains even after Robinhood reduced the number of the short-squeeze stocks traders could buy to a single share. Robinhood later expanded the list of shares with trading restrictions, including 50 names such as Starbucks Corporation (NASDAQ:SBUX) and Beyond Meat (NASDAQ:BYND), 

The CBOE Volatility Index – or so-called fear gauge – jumped rose 9%, giving investors further reason to hit pause on stocks into month-end.

Johnson & Johnson (NYSE:JNJ), meanwhile, fell 4% after it released vaccine data showing its single-shot single-dose candidate demonstrated a 66% overall efficacy rate in preventing moderate to severe Covid-19.

Despite having a lower efficacy than established mRNA vaccines from Pfizer Inc (NYSE:PFE) and Moderna Inc (NASDAQ:MRNA), JNJ's vaccine was shown to be 85% effective in preventing severe disease and hospitalizations/death, which, are "two primary drivers of the lockdowns/restrictions," BofA said in a note.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Top U.S. infectious disease specialist Anthony Fauci said the Johnson & Johnson’s vaccine news was "very encouraging" in controlling Covid-19, though added that the highly transmissible variants were a "wake up call" for the public.

Cyclical stocks including financials and energy led the broader market slump, with the latter getting hit from sluggish oil prices on fears prolonged Covid-19 restrictions will continue to hamper demand.

The broader sentiment on risk was also hurt by signs of ongoing slack in the recovery as the consumer spending fell for the second-straight, while the pace of inflation inched higher.

Consumer spending, which accounts for more than two-thirds of U.S. economic activity, fell 0.2% last month, but economists suggest the spending will rebound as the reopening of the economy will boost services activity.

"[T]he recent soft patch in spending was driven by goods rather than services … the good news is that both sources of weakness - fiscal policy and COVID - are no longer an issue as we look ahead to Q1 and beyond," Jefferies (NYSE:JEF) said in a note.

Big tech also played a role in the day of selling on Wall Street as the Fab 5 sold off sharply. 

Amazon.com (NASDAQ:AMZN), Facebook (NASDAQ:FB), Google-parent Alphabet (NASDAQ:GOOGL) and Microsoft  (NASDAQ:MSFT) traded higher, while Apple (NASDAQ:AAPL) closed more than 1% lower.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.